These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 15055161)
1. Post-transfusion acute graft versus host disease in a 17-year-old girl with a malignant mesenchymal tumor--report of a case. Utkan G; Buyukcelik A; Demir O; Sanli H; Pamir A Acta Med Austriaca; 2003; 30(5):138-41. PubMed ID: 15055161 [TBL] [Abstract][Full Text] [Related]
2. [A case of graft-versus-host disease following red cell concentrate (MAP-CRC) transfusion]. Nakamoto T; Nishi S; Shindoh M; Hayashi M; Yukioka H; Fujimori M; Maekawa N Masui; 1995 Sep; 44(9):1261-4. PubMed ID: 8523663 [TBL] [Abstract][Full Text] [Related]
3. A case of sclerodermatous graft-versus-host disease following autologous peripheral blood stem cell transplantation. Nakamura K; Kawakami Y; Oyama N; Kaneko F; Abe H; Sagara H; Ohto H J Dermatol; 2006 Feb; 33(2):135-8. PubMed ID: 16556284 [TBL] [Abstract][Full Text] [Related]
4. Prevention of post-transfusion graft-versus-host disease. Tasaki T; Ohto H; Abe R Fukushima J Med Sci; 1993 Dec; 39(2):109-11. PubMed ID: 7927133 [TBL] [Abstract][Full Text] [Related]
5. Transfusion-associated graft-vs-host disease. A fatal case caused by blood from an unrelated HLA homozygous donor. Gorman TE; Julius CJ; Barth RF; Ng A; Kennedy MS; Prior TW; Allen J; Lasky LC Am J Clin Pathol; 2000 May; 113(5):732-7. PubMed ID: 10800407 [TBL] [Abstract][Full Text] [Related]
6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
7. Transfusion-associated graft-versus-host disease in severe combined immunodeficiency. Sebnem Kilic S; Kavurt S; Balaban Adim S J Investig Allergol Clin Immunol; 2010; 20(2):153-6. PubMed ID: 20461970 [TBL] [Abstract][Full Text] [Related]
8. Graft-versus-host disease: case report and review of literature. Jing X; Halat S; Meleg-Smith S J La State Med Soc; 2006; 158(1):20-4. PubMed ID: 16602481 [TBL] [Abstract][Full Text] [Related]
9. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells. Triulzi D; Duquesnoy R; Nichols L; Clark K; Jukic D; Zeevi A; Meisner D Transfusion; 2006 Jun; 46(6):885-8. PubMed ID: 16734803 [TBL] [Abstract][Full Text] [Related]
10. Acute graft-versus-host disease of the heart. Roberts SS; Leeborg N; Loriaux M; Johnson FL; Huang ML; Stenzel P; Thiede C; Godder KT Pediatr Blood Cancer; 2006 Oct; 47(5):624-8. PubMed ID: 16206193 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis of post-transfusion graft-versus-host disease after formalin-fixation. Ryo R; Goto M; Takada M; Saigo K; Yamaguchi N; Hayashi M; Ito H; Onoyama H; Saito Y; Uchida S Int J Hematol; 1994 Jun; 59(4):297-302. PubMed ID: 8086623 [TBL] [Abstract][Full Text] [Related]
12. Myeloablative cord blood transplantation for adults with hematological malignancies using tacrolimus and short-term methotrexate for graft-versus-host disease prophylaxis: single-institution analysis. Yamada MF; Miyamura K; Fujiwara T; Kohata K; Okitsu Y; Ohguchi H; Yamamoto J; Yokoyama H; Tomiya Y; Ishizawa K; Kameoka J; Harigae H Transplant Proc; 2008 Dec; 40(10):3637-42. PubMed ID: 19100456 [TBL] [Abstract][Full Text] [Related]
14. Treatment of acute post-transfusion- graft-versus-host disease (GVHD) with intravenous human immunoglobulins: a case report. Orlandi C; Frassetto A; Gnucci E; Lehmann JR; Neri R; Melandri D J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):760-1. PubMed ID: 16836524 [No Abstract] [Full Text] [Related]
15. Severe eosinophilia as a manifestation of acute graft-versus-host disease. Paralkar VR; Goradia A; Luger SM; Loren AW Oncology; 2008; 75(3-4):134-6. PubMed ID: 18791329 [TBL] [Abstract][Full Text] [Related]
16. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation]. Lin Q; Dong M; Wang QM; Wen JY; Wu XY Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772 [TBL] [Abstract][Full Text] [Related]
17. Rapid molecular cytogenetic diagnosis of transfusion associated graft-versus-host disease by fluorescent in situ hybridization (FISH). Akay MO; Temiz G; Teke HU; Gunduz E; Acikalin MF; Isiksoy S; Durak B; Gulbas Z Transfus Apher Sci; 2008 Jun; 38(3):189-92. PubMed ID: 18487090 [TBL] [Abstract][Full Text] [Related]
18. Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative protocol. Alvarez I; Sureda A; Caballero MD; Urbano-Ispizua A; Ribera JM; Canales M; García-Conde J; Sanz G; Arranz R; Bernal MT; de la Serna J; Díez JL; Moraleda JM; Rubió-Félix D; Xicoy B; Martínez C; Mateos MV; Sierra J Biol Blood Marrow Transplant; 2006 Feb; 12(2):172-83. PubMed ID: 16443515 [TBL] [Abstract][Full Text] [Related]